Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00075
|
|||||
| EM Name |
Pyridoxic acid
|
|||||
| Synonyms |
4-Pyridoxic acid; Pyridoxic acid; 4-Pyridoxylic acid; 4-Pyridoxinic acid; 4-Pyridoxinsaeure; 4-Pyridoxinecarboxylic acid; 4-Pyridoxate; 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid; 2-Methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine; 4-Pyridoxinate; 4-Pyridoxylate; 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid; 4-Pyridoxinsaeure [German]; 4-Pyridinecarboxylic acid, 3-hydroxy-5-(hydroxymethyl)-2-methyl-; NSC 41814; UNII-5K18793O8D; 4-Pyridoxinecarboxylate
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6723"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C8H9NO4
|
|||||
| Canonical SMILES |
CC1=NC=C(C(=C1O)C(=O)O)CO
|
|||||
| InChI |
InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)
|
|||||
| InChIKey |
HXACOUQIXZGNBF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 82-82-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 183.16 | Topological Polar Surface Area | 90.6 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
0.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17405
|
|||||
| DT(s) "handling" This EM | MRP6 | Transporter Info | Multidrug resistance-associated protein 6 | [1] | ||
| MRP6 | Transporter Info | Multidrug resistance-associated protein 6 | [1] | |||
| OAT1 | Transporter Info | Organic anion transporter 1 | [2] | |||
| OAT3 | Transporter Info | Organic anion transporter 3 | [3] | |||
| OAT4 | Transporter Info | Organic anion transporter 4 | [4] | |||
| References | ||||||
| 1 | Untargeted Metabolomics Analysis of ABCC6-Deficient Mice Discloses an Altered Metabolic Liver Profile. J Proteome Res. 2016 Dec 2;15(12):4591-4600. | |||||
| 2 | Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res. 2011 Jun 3;10(6):2842-51. | |||||
| 3 | The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis. J Biol Chem. 2017 Sep 22;292(38):15789-15803. | |||||
| 4 | Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys. Drug Metab Dispos. 2018 Feb;46(2):178-188. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.